Journal article
The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL
The Journal of immunology (1950), Vol.187(9), pp.4581-4588
11/01/2011
DOI: 10.4049/jimmunol.1002241
PMCID: PMC3197947
PMID: 21940678
Abstract
An immune response of appropriate magnitude should be robust enough to control pathogen spread but not simultaneously lead to immunopathology. Primary infection with influenza A virus (IAV) results in a localized pulmonary infection and inflammation and elicits an IAV-specific CD8 T cell immune response necessary for viral clearance. Clearance of IAV-infected cells, and recovery from infection, is mediated by perforin/granzyme B- and Fas/FasL-mediated mechanisms. We recently reported that TRAIL is another means by which IAV-specific CD8 T cells can kill IAV-infected cells. The current study examined the role of TRAIL in the pulmonary CD8 T cell response to a clinically significant IAV [A/PR/8/34 (PR8; H1N1)] infection (i.e., leads to observable, but limited, morbidity and mortality in wild-type [WT] mice). Compared with WT mice, IAV-infected Trail(-/-) mice experienced increased morbidity and mortality despite similar rates of viral clearance from the lungs. The increased morbidity and mortality in Trail(-/-) mice correlated with increased pulmonary pathology and inflammatory chemokine production. Analysis of lung-infiltrating lymphocytes revealed increased numbers of IAV-specific CD8 T cells in infected Trail(-/-) mice, which correlated with increased pulmonary cytotoxic activity and increased pulmonary expression of MIG and MIP-1α. In addition, there was decreased apoptosis and increased proliferation of IAV-specific CD8 T cells in the lungs of Trail(-/-) mice compared with WT mice. Together, these data suggest that TRAIL regulates the magnitude of the IAV-specific CD8 T cell response during a clinically significant IAV infection to decrease the chance for infection-induced immunopathology.
Details
- Title: Subtitle
- The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL
- Creators
- Erik L Brincks - Department of Urology, University of Iowa, Iowa City, IA 52242, USAPrajwal GurungRyan A LangloisEmily A HemannKevin L LeggeThomas S Griffith
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.187(9), pp.4581-4588
- DOI
- 10.4049/jimmunol.1002241
- PMID
- 21940678
- PMCID
- PMC3197947
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Publisher
- United States
- Grant note
- R21 AI072032 / NIAID NIH HHS R21 AI072032-02 / NIAID NIH HHS R56 AI077565-01A1 / NIAID NIH HHS AI 072032 / NIAID NIH HHS R56 AI077565 / NIAID NIH HHS AI 077565 / NIAID NIH HHS R01 CA109446 / NCI NIH HHS
- Language
- English
- Date published
- 11/01/2011
- Academic Unit
- Microbiology and Immunology; Infectious Diseases; Pathology; Internal Medicine
- Record Identifier
- 9984047975802771
Metrics
28 Record Views